EIM
CLVS

Essex Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Essex Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-35,996
Closed -$1.06M – 549
2018
Q3 		$1.06M Buy
35,996
+20,613
+134% +$798K 0.12% 219
2018
Q2 		$699K Sell
15,383
-6,539
-30% -$318K 0.09% 267
2018
Q1 		$1.16M Buy
+21,922
New +$1.28M 0.15% 194

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Essex Investment Management's CLVS Position: Q4 2018 in Review

Essex Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 35,996 shares — an estimated $1.06M sold.

Essex Investment Management first reported a position in CLVS in Q1 2018 and held it in 3 quarters. The position peaked at $1.16M in Q1 2018. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Essex Investment Management reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Essex Investment Management sold 35,996 Clovis Oncology, Inc. shares in Q4 2018, an estimated $1.06M.
  • Essex Investment Management first reported a position in Clovis Oncology, Inc. in Q1 2018 and held it in 3 quarters.
  • Essex Investment Management's Clovis Oncology, Inc. position peaked at $1.16M in Q1 2018.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.